Techorizon Launches Feasibility Study Performance Electronic Tool

March 5, 2015
Applied Clinical Trials Editorial Staff

Applied Clinical Trials

Verona, Italy-based technology company Techorizon, announced the launch of FeRMI, an electronic application to advance the conduct of clinical trial feasibility studies.

Verona, Italy-based technology company Techorizon, announced the launch of FeRMI, an electronic application to advance the  conduct of clinical trial feasibility studies. Feasibility studies have been largely been paper or email based and are typically not integrated with other databases. 

FeRMI creates an entirely integrated, electronic approach to the conduct of feasibility studies and promotes faster, more effective study planning. Each step of the process is managed electronically, with data collection from sites completed via highly customizable online surveys which include real time error checks. The investigator database module speeds selection of potential sites and tracks previous contacts and historical study performance. A real-time reporting module allows users to track trends emerging from the feasibility study whilst in progress, and ultimately to make better decisions about site selection. 

 

Read the full release here. 

Related Content:

News